I. Martínez-Baz

发表

Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study.

J. Castilla, A. Barricarte, M. Guevara, 2012, Vaccine.

Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality

J. Castilla, M. Guevara, C. Moreno-Iribas, 2015, Medicine.

Cause of death in hospitalized patients with laboratory-confirmed influenza.

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2015, Anales del sistema sanitario de Navarra.

Impact of universal two-dose vaccination on varicella epidemiology in Navarre, Spain, 2006 to 2012.

J. Castilla, A. Barricarte, M. García Cenoz, 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Europe's journal on infectious disease epidemiology, prevention and control

J. Castilla, A. Barricarte, V. Martínez-Artola, 2013 .

Chronic obstructive pulmonary disease and influenza vaccination effect in preventing outpatient and inpatient influenza cases

J. Castilla, M. Guevara, I. Martínez-Baz, 2022, Scientific reports.

Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain

F. Pozo, J. Castilla, A. Gherasim, 2017, PloS one.

Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2017, The Journal of infectious diseases.

J. Castilla, I. Martínez-Baz, A. O'Leary, 2019, Quality of Life Research.

Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain

J. Castilla, J. Repáraz, I. Martínez-Baz, 2018, PloS one.

Detection of Respiratory Viruses in Deceased Persons, Spain, 2017

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2018, Emerging infectious diseases.

Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2022, Microbiology spectrum.

Trends in influenza vaccine coverage among primary healthcare workers in Spain, 2008-2011.

F. González-Candelas, P. Godoy, J. Castilla, 2013, Preventive medicine.

[Attitudes, perceptions and factors associated with influenza vaccination among primary healthcare professionals in Navarre, 2011-2012].

J. Castilla, M. Guevara, I. Martínez-Baz, 2013, Anales del sistema sanitario de Navarra.

Effect of influenza vaccination in patients with asthma

J. Castilla, M. Guevara, I. Martínez-Baz, 2021, Canadian Medical Association Journal.

Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021

S. de Lusignan, H. D. de Melker, M. Valenciano, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Respiratory syncytial virus hospitalization in children in northern Spain

L. Sierrasesúmaga, J. Castilla, L. Moreno-Galarraga, 2018, PloS one.

Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021

S. de Lusignan, M. Valenciano, R. Guiomar, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Invasive meningococcal disease in Navarra in the era of a meningococcal C vaccine

J. Castilla, I. Martínez-Baz, E. Bernaola, 2017 .

[Invasive meningococcal disease in Navarra in the era of a meningococcal C vaccine].

J. Castilla, I. Martínez-Baz, E. Bernaola, 2017, Anales de pediatria.

Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.

F. Pozo, J. Castilla, A. Barricarte, 2016, Vaccine.

Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Factors associated with continued adherence to influenza vaccination in the elderly.

J. Castilla, I. Martínez-Baz, J. Morán, 2012, Preventive medicine.

Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019.

F. Pozo, J. Castilla, I. Martínez-Baz, 2020, Vaccine.

Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study

J. Castilla, M. Guevara, I. Martínez-Baz, 2021, Journal of clinical medicine.

Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of Health Workers

U. Fresán, J. Castilla, I. Martínez-Baz, 2020, Vaccines.

Transmission of SARS-CoV-2 infection and risk factors in a cohort of close contacts

J. Castilla, I. Martínez-Baz, I. Casado, 2022, Postgraduate medicine.

Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis

M. Baguelin, R. Pebody, D. Levy-bruhl, 2022, Vaccine.

Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.

F. Pozo, J. Castilla, M. Guevara, 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis.

F. Pozo, J. Castilla, M. Guevara, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza.

Vicente Martín, Marc Saez, Fernando González-Candelas, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comorbidities and cardiovascular risk factors in an aged cohort of HIV-infected patients on antiretroviral treatment in a Spanish hospital in 2016

J. Castilla, I. Martínez-Baz, A. O'Leary, 2018, Postgraduate medicine.

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021

J. Castilla, M. Guevara, I. Martínez-Baz, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study

J. Castilla, M. Guevara, I. Martínez-Baz, 2023, Journal of Infection and Public Health.

Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021

J. Castilla, M. Guevara, I. Martínez-Baz, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

The prevalence of diagnosed and undiagnosed hepatitis C virus infection in Navarra, Spain, 2014-2016.

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2017, Enfermedades infecciosas y microbiologia clinica.

The prevalence of diagnosed and undiagnosed hepatitis C virus infection in Navarra, Spain, 2014–2016

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2018, Enfermedades infecciosas y microbiologia clinica (English ed.).

Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies.

E. R. van den Heuvel, E. Hak, S. la Bastide-van Gemert, 2017, The Lancet. Respiratory medicine.

Surveillance and outbreak reports Use of the vaccination register to evaluate influenza vaccine coverage in seniors in the 2010 / 11 influenza season , Navarre , Spain

J. Castilla, M. Guevara, I. Martínez-Baz, 2012 .

The prevalence of diagnosed and undiagnosed hepatitis C virus infection in Navarra, Spain, 2014-2016.

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2017, Enfermedades infecciosas y microbiologia clinica.

Economic evaluation of a population strategy for the treatment of chronic hepatitis C with direct-acting antivirals.

J. Mar, A. Arrospide, J. Castilla, 2018, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12.

F. Pozo, J. Castilla, A. Barricarte, 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022

J. Castilla, M. Guevara, I. Martínez-Baz, 2023, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Risk factors and effectiveness of preventive measures against influenza in the community

T. Pumarola, F. González-Candelas, M. Delgado-Rodríguez, 2012, Influenza and other respiratory viruses.

Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16

J. Castilla, M. Guevara, I. Martínez-Baz, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus

F. Pozo, J. Castilla, I. Martínez-Baz, 2015, Human vaccines & immunotherapeutics.

[Influence of distinct criteria for selecting patients for swabbing on estimation of the effectiveness of the influenza vaccine].

J. Castilla, M. Guevara, I. Martínez-Baz, 2014, Gaceta sanitaria.

Effect of influenza vaccination in preventing laboratory-confirmed influenza hospitalization in patients with diabetes mellitus.

U. Fresán, J. Castilla, I. Martínez-Baz, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Simple models to include influenza vaccination history when evaluating the effect of influenza vaccination

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Remaining effect of influenza vaccines received in prior seasons.

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2019, The Journal of infectious diseases.

Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18

F. Pozo, J. Castilla, I. Martínez-Baz, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis

F. Pozo, J. Castilla, I. Martínez-Baz, 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010–2011: a population-based test-negative case–control study

J. Castilla, M. Guevara, V. Martínez-Artola, 2013, BMC Public Health.

Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.

J. Castilla, A. Barricarte, M. Guevara, 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study

M. Valenciano, S. Buda, R. Guiomar, 2022, Influenza and other respiratory viruses.

Household Transmission of Influenza A(H1N1)pdm09 in the Pandemic and Post-Pandemic Seasons

J. Castilla, I. Martínez-Baz, F. Irisarri, 2014, PloS one.

Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22

F. Pozo, J. Castilla, I. Martínez-Baz, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022

J. Starrfelt, A. Nardone, M. Valenciano, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Absence of association between 2019‐20 influenza vaccination and COVID‐19: Results of the European I‐MOVE‐COVID‐19 primary care project, March‐August 2020

M. Valenciano, A. Meijer, A. Carnahan, 2021, Influenza and other respiratory viruses.

Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis.

J. Castilla, V. Martínez-Artola, E. Salcedo, 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Long-term changes on health-related quality of life in patients with chronic hepatitis C after viral clearance with direct-acting antiviral agents.

J. Herrero, J. Castilla, I. Martínez-Baz, 2019, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza.

O. Garin, T. Pumarola, F. González-Candelas, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of Repeated Vaccination With the Same Vaccine Component Against Influenza A(H1N1)pdm09.

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2017, The Journal of infectious diseases.

Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients

J. Cabasés, J. Castilla, I. Martínez-Baz, 2018, PloS one.

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021

J. Castilla, M. Guevara, I. Martínez-Baz, 2021, Eurosurveillance.

Survival and clinical events related to end-stage liver disease associated with HCV prior to the era of all oral direct-acting antiviral treatments

J. Mar, J. Castilla, I. Martínez-Baz, 2019, Expert review of gastroenterology & hepatology.

Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies.

E. R. van den Heuvel, E. Hak, S. la Bastide-van Gemert, 2017, The Lancet. Respiratory medicine.

Rapid communications Rabies in an Arctic fox on the Svalbard archipelago

R. Konrad, B. Ytrehus, T. Vikøren, 2011 .

Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study

A. Carnahan, V. Enouf, M. Hooiveld, 2024, Influenza and Other Respiratory Viruses.

Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022–23 VEBIS multicentre study in Europe

M. Hooiveld, A. Larrauri, E. Kissling, 2024, Vaccine.

Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024

M. Hooiveld, E. Kissling, B. Oroszi, 2024, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study.

J. Castilla, A. Barricarte, M. Guevara, 2012, Vaccine.

Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13

A. N. Robertson, D. Fleming, C. Robertson, 2013 .